Hideki Ohta

Title: Innovations of Inventor Hideki Ohta

Introduction

Hideki Ohta is a notable inventor based in Toyonaka, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies and angiogenesis inhibitors. With a total of 4 patents, Ohta's work has the potential to impact medical research and therapeutic applications.

Latest Patents

One of Ohta's latest patents is a monoclonal antibody for detecting exosomes. This invention includes antibodies that recognize specific amino acid sequences, allowing for the detection of CD9, CD63, or CD81 on exosomes with excellent sensitivity and specificity. Another significant patent is related to an angiogenesis inhibitor, which highlights the angiogenesis inhibitory activity of AK022567. This compound, along with four splicing variants from the same gene, is useful for screening candidate compounds as angiogenesis inhibitors or promoters, potentially leading to new therapeutic agents for angiogenesis-related diseases.

Career Highlights

Throughout his career, Hideki Ohta has worked with reputable companies such as Shionogi Company Limited and Cosmo Bio Co., Ltd. His experience in these organizations has contributed to his expertise in the field of biotechnology and patent development.

Collaborations

Ohta has collaborated with notable coworkers, including Hikaru Sonoda and Yasufumi Sato. Their joint efforts have likely enhanced the innovation and research outcomes in their respective projects.

Conclusion

Hideki Ohta's contributions to biotechnology through his patents and collaborations demonstrate his commitment to advancing medical science. His work in monoclonal antibodies and angiogenesis inhibitors holds promise for future therapeutic developments.